44 results on '"Ahmad, Syed A."'
Search Results
2. Tu2051 INSIGHTS INTO THE EXPLANTED PANCREAS AND ISLET YIELD: THE ROLE OF IMAGING MARKERS IN PEDIATRIC TOTAL PANCREATECTOMY ISLET AUTOTRANSPLANTATION
3. Tu1211 CABOZANTINIB INCREASES THE EFFICACY OF PEMBROLIZUMAB IN HUMAN PANCREATIC DUCTAL ADENOCARCINOMA ORGANOID COCULTURES
4. Su1202 TARGETING THE CD44 VARIANT ISOFORMS USING A NOVEL CDC-LIKE PROTEIN KINASE INHIBITOR TO IMPROVE THE EFFICACY OF STANDARD-OF-CARE THERAPY FOR PANCREATIC DUCTAL ADENOCARCINOMA
5. 1149 PRE TPIAT OPIOID USE AND SMOKING STATUS WERE INDEPENDENTLY ASSOCIATED WITH HIGHER ODDS OF DAILY OPIOID USE AT 1 YEAR POST TPIAT-RESULTS FROM THE PROSPECTIVE OBSERVATIONAL STUDY OF TPIAT (POST) COHORT
6. 298 POST-PANCREATECTOMY VOLUMETRIC ANALYSIS: A MISSING VARIABLE IN THE DEVELOPMENT OF POST-OPERATIVE ENDOCRINE AND EXOCRINE DYSFUNCTION
7. Fr339 PANCREATITIS AND OPIOID GENE VARIANTS ARE ASSOCIATED WITH PREOPERATIVE OPIOID USE: PRELIMINARY DATA FROM THE POST COHORT
8. Tu1027 CLINICAL CHARACTERISTICS AND OUTCOMES OF HISPANIC SUBJECTS COMPARED TO NON-HISPANIC SUBJECTS WHO HAD TOTAL PANCREATECTOMY AND ISLET AUTOTRANSPLANTATION (TPIAT) FOR PANCREATIC DISEASE.
9. Mo1050 CABOZANTINIB TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA PROMOTES A STROMAL ENVIRONMENT THAT IS CONDUCIVE TO IMMUNOTHERAPY
10. 788 LACK OF NATIONAL ADOPTION OF EVIDENCE-BASED TREATMENT FOR RESECTABLE GASTRIC ADENOCARCINOMA
11. Mo1051 CD44 VARIANT ISOFORM 9 AND ITS ROLE IN PANCREATIC DUCTAL ADENOCARCINOMA STEM CELL SURVIVAL POST STANDARD-OF-CARE CHEMOTHERAPY
12. Sa1373 PREOPERATIVE ERCP HAS NO IMPACT ON ISLET CELL YIELD FOLLOWING TOTAL PANCREATECTOMY AND ISLET TRANSPLANTATION (TPIAT): RESULTS FROM THE PROSPECTIVE OBSERVATIONAL STUDY OF TPIAT (POST) COHORT
13. 590 AN ORGANOID-IMMUNE CELL CO-CULTURE PREDICTIVE MODEL TO TARGET HER2/PD-L1 POSITIVE GASTRIC CANCERS
14. Surgery for Pancreatic Cancer: Recent Controversies and Current Practice
15. 740 – Indications for and Factors Associated with 30-Day Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Study from the US Hipec Collaborative
16. 231 – Should We Be Doing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma? a Study from the US Hipec Collaborative
17. Human-Derived Gastric Cancer Organoids Secrete Tumor Antigen that Activates Dendritic Cells and Subsequent Expression of PD-1 and CTLA-4 on Cytotoxic T Lymphocytes
18. Patient-Derived in vitro and in vivo Organoid Models of Gastric Cancer
19. Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals
20. Are All Pancreatic Fistulas Created Equal? An Analysis of Fistula Rates and Severity Based on Operative Management for Head-Predominant Chronic Pancreatitis and Periampullary Malignancies
21. Tu1513 Does Radiologic Response Correlate to Pathologic Response in Patients Undergoing Neoadjuvant Therapy for Pancreatic Malignancy?
22. Su1404 Fistulojejunostomy Versus Distal Pancreatectomy for the Management of Disconnected Duct and Distal Pancreas
23. 29 Helicobacter pylori Induces the Expression of Gastric Cancer Stem Cell Marker CD44v via the Inhibition of p53 Resulting in Epithelial Hyperproliferation and Oncogenic Transformation
24. 861 Cost Effectiveness in Hepatic Lobectomy: The Volume Effect on Resource Utilization
25. Su1781 Whipples in Octogenarians: Patient Selection Trumps Ageism
26. 485 Perception Is Reality: Quality Metrics in Pancreatic Surgery - A Central Pancreas Consortium (CPC) Analysis of 1399 Patients
27. Mo1632 Readmission Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis – Can We Predict (or Avoid) Them?
28. 479 Patients With Resected Gallbladder Cancer Demonstrate Improved Survival With Adjuvant Therapy
29. Tu1393 - Are All Pancreatic Fistulas Created Equal? An Analysis of Fistula Rates and Severity Based on Operative Management for Head-Predominant Chronic Pancreatitis and Periampullary Malignancies
30. 338 - Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals
31. 447 - Patient-Derived in vitro and in vivo Organoid Models of Gastric Cancer
32. 196 - Human-Derived Gastric Cancer Organoids Secrete Tumor Antigen that Activates Dendritic Cells and Subsequent Expression of PD-1 and CTLA-4 on Cytotoxic T Lymphocytes
33. Tu1619 Socioeconomic Status and Access to Care: Do They Influence Outcomes in Pancreaticoduodenectomy?
34. 369 Cost-Effectiveness of Total Pancreatectomy With Islet Cell Autotransplantation for the Treatment of Small Duct Chronic Pancreatitis
35. 709 Perioperative Blood Transfusion Reduces Survival in Patients With Pancreatic Adenocarcinoma: A Multi-Institutional Study of 698 Patients
36. 924 Venous Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of “Borderline Resectable Disease”?
37. 729 Pre-Operative Imaging Does Not Accurately Stage Patients With Early Stage Appendiceal Cancer
38. 798 Medically Managed Hypercholesterolemia and Insulin-Dependent Diabetes Mellitus Preoperatively Predicts Poor Survival After Surgery for Pancreatic Cancer
39. Biliary fistulas following hepatic resection: Risk factors and treatment strategies
40. A comparison of the harmonic scalpel with clamp crushing technique for hepatic resection
41. Initial results of islet auto-transplantation in 16 patients suffering from severe chronic pancreatitis
42. Hepatitis serology as a prognostic factor in patientswith hepatocellular carcinoma
43. The role of CCK-HIDA scan in the diagnosis and treatment of chronic acalculous cholecystitis
44. S1327 A Dilated Pancreatic Duct Seen On Pre-Operative ERCP Predicts Poorer Post-Operative Quality of Life After Total Pancreatectomy with Autologous Islet Cell Transplantation for Chronic Pancreatitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.